Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 07-2010 | 04-2010 | 01-2010 | 10-2009 | 07-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,002 | N/A | -7,740 | -4,986 | -2,397 |
| Depreciation Amortization | 133 | N/A | 91 | 55 | 26 |
| Accounts receivable | 139 | N/A | -647 | -401 | -82 |
| Other Working Capital | 144 | N/A | 26 | 707 | -64 |
| Other Operating Activity | -28 | 0 | 1,975 | 1,792 | 988 |
| Operating Cash Flow | $-2,613 | $N/A | $-6,294 | $-2,833 | $-1,528 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -89 | N/A | -175 | -63 | -13 |
| Purchase Sale Intangibles | -70 | N/A | -208 | -174 | -74 |
| Other Investing Activity | -70 | 0 | -208 | -174 | -74 |
| Investing Cash Flow | $-159 | $N/A | $-383 | $-237 | $-87 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 97 | N/A | N/A |
| Common Stock Issued | 4,901 | N/A | 9,793 | 4,362 | 4,425 |
| Common Stock Repurchased | N/A | N/A | -2,837 | -2,837 | -2,837 |
| Other Financing Activity | -30 | 0 | -56 | -37 | -27 |
| Financing Cash Flow | $4,872 | $N/A | $6,997 | $1,489 | $1,561 |
| Beginning Cash Position | 633 | N/A | 2,556 | 2,556 | 2,556 |
| End Cash Position | 2,732 | N/A | 2,876 | 975 | 2,502 |
| Net Cash Flow | $2,099 | $N/A | $321 | $-1,581 | $-54 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,613 | N/A | -6,294 | -2,833 | -1,528 |
| Capital Expenditure | -89 | N/A | -175 | -63 | -13 |
| Free Cash Flow | -2,702 | 0 | -6,469 | -2,896 | -1,541 |